π΅οΈ Dentsply Sirona Inc. ($XRAY)
SEC insider & ownership activity, last 12 months Β· CIK 818479 Β· every row links its SEC filing
Over the last 12 months insiders sold $916K against $1.7M of open-market buying. Gregory T. Lucier sold $916K in discretionary trades (DecβMar). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
9 buyers, $1.7M (12 lots) Β· 1 seller, $916K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Gregory T. Lucier | 3 | $894K | 1 | $916K | Mar 9, 2026 |
| Michael J. Barber | 1 | $150K | 0 | β | Jun 11, 2026 |
| James D. Forbes | 2 | $130K | 0 | β | Mar 9, 2026 |
| Mazelsky Jonathan Jay | 1 | $101K | 0 | β | Jun 12, 2026 |
| Brian P. McKeon | 1 | $101K | 0 | β | Jun 12, 2026 |
| Brian T. Gladden | 1 | $100K | 0 | β | Jun 15, 2026 |
| Leslie F. Varon | 1 | $100K | 0 | β | Nov 24, 2025 |
| Betsy D. Holden | 1 | $100K | 0 | β | Jun 11, 2026 |
| Hosein Clyde | 1 | $65K | 0 | β | Jun 15, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 12.6% | 13G | Jul 8, 2026 | filing β | |
| Vanguard Portfolio Management | 5.4% | 13G | Apr 29, 2026 | filing β | |
| Vanguard Capital Management | 5.3% | 13G | Apr 29, 2026 | filing β | |
| Southpoint Master Fund, LP | 5.0% | 13G | Mar 18, 2026 | filing β | |
| Southpoint Capital Advisors LP | 5.0% | 13G | Mar 18, 2026 | filing β | |
| Southpoint Capital Advisors LLC | 5.0% | 13G | Mar 18, 2026 | filing β | |
| Southpoint GP, LP | 5.0% | 13G | Mar 18, 2026 | filing β | |
| Southpoint GP, LLC | 5.0% | 13G | Mar 18, 2026 | filing β | |
| John S. Clark II | 5.0% | 13G | Mar 18, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Gregory T. Lucier | $912K | Dec 8, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 11, 2026 | filing β |
| Reg FD disclosure (7.01) | Jun 11, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing β |
| Shareholder vote (5.07) | Jun 2, 2026 | filing β |
| Earnings (2.02) | May 5, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing β |
| Earnings (2.02) | Feb 26, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing β |
| Officer/director changes (5.02) | Feb 23, 2026 | filing β |
| Reg FD disclosure (7.01) | Feb 23, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing β |
| Reg FD disclosure (7.01) | Jan 14, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 14, 2026 | filing β |
| Officer/director changes (5.02) | Jan 10, 2026 | filing β |
| Reg FD disclosure (7.01) | Jan 10, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Jan 10, 2026 | filing β |
| Material agreement (1.01) | Dec 24, 2025 | filing β |
| New financial obligation (2.03) | Dec 24, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Dec 24, 2025 | filing β |
| Other events (8.01) | Nov 25, 2025 | filing β |
| Earnings (2.02) | Nov 6, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing β |
| Officer/director changes (5.02) | Oct 31, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Oct 31, 2025 | filing β |
| Officer/director changes (5.02) | Oct 31, 2025 | filing β |
| Other events (8.01) | Oct 14, 2025 | filing β |
| Officer/director changes (5.02) | Oct 2, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Oct 2, 2025 | filing β |
| Officer/director changes (5.02) | Sep 19, 2025 | filing β |
| Reg FD disclosure (7.01) | Sep 8, 2025 | filing β |